Liverpool-Heart and BRain Project Stroke Cohort
L-HARP
1 other identifier
observational
1,655
1 country
1
Brief Summary
What research question is being addressed? Can improve the prediction of adverse outcomes be improved for people following a stroke to optimise their treatment and care? How is it of relevance and importance to patients and public? Following a stroke, people are at a higher risk of developing certain conditions including heart failure, another stroke and atrial fibrillation, a type of irregular heart rhythm. In the proposed study, the investigators will look at factors which may increase a person's risk of such conditions following stroke. From this, the investigators will determine if risk scores for these conditions can be improved for people post-stroke. This could help doctors decide what treatments are best. Who would be eligible? All adults at participating hospitals who have had an ischaemic stroke (where the stroke is caused by loss of blood flow to the brain) or a transient ischaemic attack ('mini-stroke') confirmed by a stroke doctor. All patients will be asked to take part in the study, or their family members may be asked to provide advice on their behalf if the patient is unable to. Where is the study being conducted? At participating hospitals in England and Wales. What will the participants undergo? At the time of stroke, patients have a lot of information collected about their health, the investigators will copy information from patient's medical records about their health after they agree to take part in the study. Patients or their family members will also be asked to complete some additional brief questionnaires about their quality of life, wellbeing and fatigue. Some questionnaires such as for cognitive function are already collected for patients following a stroke, but where this information has not been collected, it will be collected for the study. The investigators will ask the patients if they can be contacted in 12-months to repeat the questionnaires and information collected about their health.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2021
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 12, 2021
CompletedFirst Submitted
Initial submission to the registry
November 12, 2021
CompletedFirst Posted
Study publicly available on registry
November 24, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 10, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 10, 2024
CompletedFebruary 21, 2025
March 1, 2024
2.7 years
November 12, 2021
February 19, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Number of participants with incident stroke, transient ischaemic attack, atrial fibrillation, myocardial infarction and heart failure
Incident stroke, transient ischaemic attack, atrial fibrillation, myocardial infarction and heart failure
12 months
Mortality
All-cause mortality and mortality from cardiovascular causes
12 months
Number of participants with incident cognitive impairment
Cognitive impairment determined from Montreal Cognitive Assessment (MoCA) test results
12 months
Number of participants with incident dementia
Dementia determined from clinical diagnosis
12 months
Eligibility Criteria
All patients from participating hospitals with a recent ischaemic stroke confirmed by stroke physician or transient ischaemic attack confirmed by MRI are eligible unless they are received palliative or end-of-life care. This study aims to be as inclusive as possible with recruitment and provide methods for advice to be sought from a personal consultee (relative/friend/carer) where informed consent is not possible in line with the Mental Capacity Act 2005.
You may qualify if:
- ≥18 years old
- Current in-patient at a participating hospital the time of baseline data collection for recent ischaemic stroke confirmed by stroke physician or transient ischaemic attack confirmed by magnetic resonance imaging (MRI)
You may not qualify if:
- Inability to provide informed consent and no personal consultee available or personal consultee does not think the person would want to participate
- Receiving palliative or end-of-life care
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Countess of Chester Hospital
Chester, CH2 1UL, United Kingdom
Related Publications (1)
Harrison SL, Lane DA, Buckley BJR, Chatterjee K, Alobaida M, Shipley E, Lip GYH. The Liverpool Heart And bRain Project (L-HARP): Protocol for an Observational Cohort Study of Cardiovascular Risk and Outcomes Following Stroke. Vasc Health Risk Manag. 2022 Apr 26;18:313-318. doi: 10.2147/VHRM.S357829. eCollection 2022.
PMID: 35502192DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Stephanie L Harrison, PhD
University of Liverpool
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 12 Months
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 12, 2021
First Posted
November 24, 2021
Study Start
October 12, 2021
Primary Completion
June 10, 2024
Study Completion
June 10, 2024
Last Updated
February 21, 2025
Record last verified: 2024-03
Data Sharing
- IPD Sharing
- Will not share